Zhengye Biotechnology Holding (ZYBT) Long-Term Investments (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Long-Term Investments for 3 consecutive years, with $30.5 million the latest figure, recorded in Q4 2025.

• Quarterly Long-Term Investments fell 22.77% year-over-year to $30.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.5 million (down 22.77% YoY) and the FY2025 annual result came in at $31.0 million, down 20.42% from the prior year.
• Long-Term Investments eased to $30.5 million in Q4 2025 per ZYBT's latest filing, from $39.5 million in the prior quarter.
• Over the last five years, Long-Term Investments for ZYBT reached as high as $39.5 million in Q4 2024 and fell as low as $30.5 million in Q4 2025.
• A 3-year average of $36.0 million and a median of $37.9 million in 2023 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2024 — Long-Term Investments gained 4.32% — and 2025, when it declined 22.77%.
• Year by year, Long-Term Investments stood at $37.9 million in 2023, then advanced by 4.32% to $39.5 million in 2024, then slipped by 22.77% to $30.5 million in 2025.
• According to Business Quant data, Long-Term Investments over the past three periods registered $30.5 million, $39.5 million, and $37.9 million for Q4 2025, Q4 2024, and Q4 2023 respectively.